Levothyroxine is a synthetic levoisomer of thyroxine. Currently, it is one of the most commonly prescribed drugs worldwide. The main indication for levothyroxine treatment is hypothyroidism of any type. It is also used for suppression therapy in patients with thyroid cancer. The therapeutic dose depends on the residual thyroid secretion, the weight of the patient, and the purpose of the treatment. The initial dose typically ranges from 25 to 50 μg daily, with further adjustment according to the level of thyroid-stimulating hormone (TSH). Initial dose titration is not recommended during postoperative replacement therapy and in pregnant women with hypothyroidism. Most of the plasma thyroxine is bound to transport proteins. However, only the free thyroxin is biologically active. Thyroxine is mainly a prohormone which is metabolized to the more active triiodothyronine. Properly managed levothyroxine treatment is safe with minimal adverse effects. Palpitations and other symptoms of hyperthyroidism may occur with overdose. For proper absorption, levothyroxine should be taken on an empty stomach, separately from other medications, at least 30 minutes before breakfast. Absorption may be impaired by other medications, especially by those increasing the pH of gastric acid.
左甲状腺素是甲状腺素的合成左旋异构体。目前,它是全球最常用的处方药之一。左甲状腺素治疗的主要适应证是任何类型的甲状腺功能减退症。它也用于甲状腺癌患者的抑制治疗。治疗剂量取决于残余甲状腺分泌量、患者体重和治疗目的。初始剂量通常为每日25至50μg,根据促甲状腺激素(TSH)水平进一步调整。术后替代治疗期间和甲状腺功能减退的孕妇不建议进行初始剂量滴定。大部分血浆甲状腺素与转运蛋白结合。然而,只有游离甲状腺素具有生物活性。甲状腺素主要是一种前激素,可代谢为活性更强的三碘甲状腺原氨酸。正确管理的左甲状腺素治疗是安全的,不良反应极少。过量服用可能会出现心悸和其他甲状腺功能亢进症状。为了达到良好的吸收效果,左甲状腺素应空腹服用,与其他药物分开,至少在早餐前30分钟服用。其他药物可能会影响吸收,尤其是那些会提高胃酸pH值的药物。